1,
Grema HA, Geidam YA, Gadzama GB, Ameh JA, Suleiman A.
Methicillin-resistant Staphylococcus aureus (MRSA): A review.
Advances in Animal and Veterinary Science. 2014; 3(2); 79-98.
2,
Umaru GA, Kabiru J, Adamu NB, UmarYA.
A review of emerging methicillin-resistant Staphylococcus aureus (MRSA): A growing threat to Veterinarians.
Nigerian Veterinary Journal. 2011; 32(3); 174-186.
3,
Tietz A, Frei R, Windmer AF.
Transatlantic spread of the USA300 clone of MRSA.
New Engl J Med. 2005; 353(5); 532-533.
4,
Donnio PY, Preney L, Gautier-Lerestif AL, Avril JL, Lafforgue N.
Changes in staphylococcal cassette chromosome type and antibiotic resistance profile in methicillin-resistant Staphylococcus aureus isolates from a French hospital over and 11 years period.
J Antimicrob Chemother 2004; 53(5); 808-813.
5,
Monecke S, Coombs G, Shore AC, Coleman DC, Akpaka P, Ehricht R, et al.
A field guide to pandemic, epidemic and sporadic clones of methicillin-resistant Staphylococcus aureus.
PLoS One. 2011; 6; e17936.
6,
Lee JH.
Methicillin (Oxacillin)-resistant Staphylococcus aureus strains isolated from major food animals and their potential transmission to humans.
Appl Environ Microbiol. 2003; 69(11); 6489-6494.
7,
Tran TT, Munita JM, Arias CA.
Mechanisms of drug resistant: daptomycin resistant.
Ann N. Y. Acad Sci. 2015; 1354; 32-53.
8,
Muraih JK, Pearson A, Silverman J, Palmer M. (2011).
Oligomerization of daptomycin on membranes.
Biochemica et Biophysica Acta. 1808; 1154-1160.
9,
Ho SW, Jung D, Calhoun JR, Lear JD, Okon M, Straus SK, et al.
Effect of divalent cations on the structure of the antibiotic daptomycin.
Eur Biophys J. 2008; 37; 421-433.
10,
Strauss SK, Hancock RW.
Mode of action of the new antibiotic for gram-positive pathogens daptomycin: comparison with cationic antimicrobial peptides and lipopeptides.
Biochim Biophys Acta. 2006; 1758(9); 1215-1223.
11,
Scott WR, Beak SB, Jung D, Hancock RE, Straus SK.
NMR structural studies of the antibiotic lipopeptide daptomycin in DHPC micelles.
Biochim Biophys Acta. 2007; 1768(12); 3116-3126.
12,
Bayer AS, Schneider T, Sahl HG.
Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall.
Ann N. Y. Acad Sci. 2013; 1277; 139-158.
13,
Roveta S, Marchese A, Schito GC.
Activity of daptomycin on biofilms produced on a plastic support by Staphylococcus spp.
Int J Antimicrob Agents. 2008; 31(4); 312-328.
14,
Malizos K, Sarma J, Seaton RA, Militz M, Menichetti F, Hamed K, et al.
Daptomycin for the treatment of osteomyelitis and orthopedic device infections: real-world clinical experience from a European registry.
Eur J Clin Microbiol Infect Dis. 2016; 35; 111-118.
15,
Ernst CM, Staubitz P, Mishra NN, Yang SJ, Hornig G, Peschel A, et al.
The bacterial defencin resistance protein MprF consists of separable domains for lipid lysinylation and antimicrobial peptide repulsion.
PLoS ONE. 2009; 5(11); e1000660.
16,
Mishra NN, Yang SJ, Sawa A, Rubio A, Nast CC, Bayer AS, et al.
Analysis of cell membrane characteristics of in vitro-selected daptomycin-resistant strains of methicillin-resistant Staphylococcus aureus.
Antimicrob Agents Chemother. 2009; 53(6); 2312-2318.
17,
Kanesaka I, Fujisaki S, Aiba Y, Watanabe S, Mikawa T, Kobayashi I, et al.
Characterization of compensatory mutations associated with restoration of daptomycin-susceptibility in daptomycin non-susceptible methicillin-resistant Staphylococcus aureus and the role mprF mutation.
J infect Chemother. 2091; 25(1); 1-5.
18,
Kuroda M, Ohta T, Uchiyama I, Baba T, Yuzawa H, Hiramatsu K, et al.
Whole genome sequencing of methicillin-resistant Staphylococcus aureus.
Lancet. 2001; 357(9264); 1225-1240.
19,
Yang SJ, Mishra NN, Kang KM, Lee GY, Park JH, Bayer AS.
Impact of multiple single-nucleotide polymorphisms within mprF on daptomycin resistance in Staphylococcus aureus
Microb Drug Resist. 2018; 24(8); 1075-1081.
20,
Bayer AS, Mishra NN, Chen L, Kreiswirth BN, Rubio A, Yang SJ.
Frequency and distribution of single-nucleotide polymorphisms within mprF in methicillin-resistant Staphylococcus aureus clinical isolates and their role in cross-resistance to daptomycin and host defense antimicrobial peptides.
Antimicrob Agents Chemother. 2015; 59(8); 4930-4937.
21,
Kini RM, Evans HJ.
A novel approach to the design of potent bioactive peptides by incorporation of proline brackets: antiplatelet effects of Arg-Gly-Asp peptide.
FEBS Letters. 1995; 375(1,2); 15-17.
22,
Iwata Y, Satou K, Tsuzuku H, Furuichi K, Senda Y, Wada T, et al.
Down-regulation of the two-component system and cell-wall biosynthesis-related genes was associated with the reversion to daptomycin susceptibility in daptomycin non-susceptible methicillin-resistant Staphylococcus aureus.
Eur J Clin Microbiol Infect Dis. 2017; 36(10); 1839-1845.
23,
Yang SJ, Nast CC, Mishra NN, Yeaman MR, Fey PD, Bayer AS.
Cell wall thickening is not a universal accompaniment of the daptomycin nonsusceptibility phenotype in Staphylococcus aureus: evidence for multiple resistance mechanisms.
Antimicrob Agents Chemother. 2010; 54(8); 3079-3085.
24,
Mishra NN, Bayer AS, Weidenmaier C, Grau T, Wanner S, Yang SJ, et al.
Phenotypic and genotypic characterization of daptomycin-resistant methicillin-resistant Staphylococcus aureus strains: Relative role of mprF and dlt operons.
PLoS ONE. 2014; 9(9); e107426.
25,
Draper L, Cotter PD, Hill C, Ross RP.
Lantibiotic resistance
Microbiol Mol Biol Rev. 2015; 79(2); 171-191.
26,
Mishra NN, McKinnell J, Yeaman MR, Rubio A, Nast CC, Bayer AS, et al.
In vitro cross-resistance to daptomycin and host defense cationic antimicrobial peptides in clinical methicillin-resistant Staphylococcus aureus isolates.
Antimicrob Agents Chemother. 2011; 55(9); 4012-4018.
27,
Fleitas O, Franco OL.
Induced bacterial cross-resistance toward host antimicrobial peptides: a worrying phenomenon.
Front Microbiol. 2016; 7; 381.
28,
Roch M, Gagetti P, Davis J, Ceriana P, Errecalde L, Rosatp AE, et al.
Daptomycin resistance in clinical MRSA strains is associated with a high biological fitness cont.
Front Microbiol. 2017; 8; 2303.
29,
Li S, Yin Y, Chen H, Wang Q, Wang X, Wang H.
Fitness cost of daptomycin-resistant Staphylococcus aureus obtained from in vitro daptomycin selection pressure.
Front Microbiol. 2017; 8; 2199.
30,
Suzuki M, Tawada Y, Kato M, Hori H, Mamiya N, Sakae K, et al.
Development of a rapid strain differentiation method for methicillin-resistant Staphylococcus aureus isolated in Japan by detecting phage-derived open-reading frames.
J Appl Microbiol. 2006; 101(4); 938-947.
31,
Suziki M, Matsumoto M, Takahashi M, Hayakawa Y, Minagawa H.
Identification of the clonal complexes of Staphylococcus aureus strains by determination of the conservation patterns of small genomic islets.
J Appl Microbiol. 2009; 107(4); 1367-1374.
32,
Schneewind O, Missiakas D.
Genetic manipulation of Staphylococcus aureus.
Curr Protoc Microbiology. 2014; 1(773); 1-23.
33,
Yang SJ, Kreiswirth BN, Sakoulas G, Yeaman MR, Xiong YQ, Bayer AS, et al.
Enhanced expression of dltABCD is associated with development of daptomycin nonsusceptibility in a clinical endocarditis isolate of Staphylococcus aureus.
J Infect Dis. 2009; 200(12); 1916-1920.
34,
Yang SJ, Nast CC, Mishra NN, Yeaman MR, Fey PD, Bayer AS.
Cell wall thickness is not a universal accompaniment of the daptomycin nonsusceptibility phenotype in Staphylococcus aureus: evidence for multiple resistance mechanism
Antimicrob Agents Chemother. 2010; 54(8); 3079-3085.
35,
Yang SJ, Bayer AS, Mishra NN, Meehl M, Ledala N, Cheung AL, et al.
The Staphylococcus aureus two-component regulatory system, GraRS, senses and confers resistance to selected cationic antimicrobial peptides
Infect Immun. 2012; 80(1); 74-81.